Mayo, Anthony J., Joshua D. Margolis, and Amy Gallo. "Give Your Colleague the Rating He Deserves—or the One He Wants?" Harvard Business Review 98, no. 1 (January–February 2020): 140–144.

On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $42.05 which represents a decrease of $-1.61 or -3.69% from the prior close of $43.66. The stock opened at $43.13 and touched a ...